19/DRA/DC/Notification/2016-2017/40
Regulatory Notification
DRA would like to notify that the application fee for product dossier assessment has been revised to Nu. 500 (Five hundred) based on the consensus of the stakeholders and approval from the Sixteenth meeting of the Bhutan Medicines Board. This is notification shall come into force from 03 August, 2017.
Please click on the link below to view the Notification:
April 14th, 2022
April 6th, 2022
March 31st, 2022
March 30th, 2022
February 17th, 2022
February 13th, 2022